PDFs der letzten Seminare zum Download
The good, the bad, the ugly!? Experimental coverage in Germany.
The pragmatic reimbursement pathways in Austria?! (30.09.2021).
Price negotiations in Germany (26.08.2021).
German elections ahead (29.07.2021).
1 year DiGAs in Germany – Garden of Eden? (24.06.2021)
The end in drug price negotiations in Germany? (27.05.2021)
Access to German hospitals – pathways to follow (29.04.2021)
10 years AMNOG – What have we learnt for drug development and pricing? (25.03.2021)
The alps, cheese, banks and early paid access for drugs! (25.02.2021)
Digital Health in Germany: Start of a rocket or just a big bluff? (28.01.2021)
The end of Covid-19 due to vaccines? (17.12.2020)
The potential impact of the 2020 US presidential election (24.11.2020)
Innovative price contracting in the German AMNOG process (29.10.2020)
Market access & reimbursement for health apps (24.09.2020)
A possible second wave of Covid-19 in Germany (25.06.2020)
